Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹18 Cr₹60 Cr₹58 Cr₹46 Cr₹58 Cr

What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?

The latest Total Non-Current Liabilities ratio of VENUS REMEDIES is ₹18 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹18 Cr
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹46 Cr
Mar2021₹58 Cr

How is Total Non-Current Liabilities of VENUS REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹18 Cr
-69.12
Mar2024 ₹60 Cr
2.89
Mar2023 ₹58 Cr
26.60
Mar2022 ₹46 Cr
-20.94
Mar2021 ₹58 Cr -

Compare Total Non-Current Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,164.5 Cr 0.2% 22.9% 197.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.2%

22.9%

197.2%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses